Skip to main content

Table 1 Relationship between patient intratumor Cul4B and clinicopathologic features

From: Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1

Variable

Intratumor Cul4B

Low expression (n = 64)

High expression (n = 64)

p

Age (years)

 < 50

13

21

0.109

 ≥50

51

43

 

Pathological type

 Non-serous tumour

37

32

0.375

 Serous tumour

27

32

 

Tumor grade

 1

10

9

0.804

 2–3

54

55

 

Tumor size

 < 10 cm

24

25

0.856

 ≥10 cm

40

39

 

FIGO

 I-II

50

39

0.035

 III-IV

14

25

 

CA125

 < 70 U/L

27

29

0.581

 ≥70 U/L

36

35

Â